Ensayos Clínicos

Entyvio (vedolizumab) long-term safety study: an international observational prospective cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or Crohn's Disease.

Ficha Técnica

Investigador Principal

JOSE MANUEL BENITEZ CANTERO

Promotor

TAKEDA GLOBAL RESEARCH&DEVELOPMENT CENTRE LTD

ESTADO

ACTIVO

DEPARTAMENTO

Aparato Digestivo

Número protocolo: TAK-VED-2016-01 (MLN-0002_401)

Fecha Inicio: 2018-11-23

Fecha Fin: 2022-02-23